Risk-adapted approach for fever and neutropenia in paediatric cancer patients – A national multicentre study
Karin G. E. Miedema(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Erna Michiels(Princess Máxima Center), Michel J. van Vliet(University Medical Center Groningen), Hester A. de Groot‐Kruseman(Stichting Kinderoncologie Nederland), Marianne D. van de Wetering(Amsterdam UMC Location University of Amsterdam), Obbe F. Norbruis(Isala), Wilma Y. de Vries(University Medical Center Groningen), Wim J. E. Tissing(University Medical Center Groningen), Willem A. Kamps(Pediatric Oncology Group), Marta Fiocco(Leiden University Medical Center), Lynne M. Ball(Leiden University Medical Center), Floor Abbink(Amsterdam University Medical Centers)
Cited by 60
Related Papers
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932
Evidence Based Selection of Housekeeping Genes
|PLoS ONE|2007|772
Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2000|599